Abnormal expression of specific molecules such as glucose, apolipoprotein, fatty acid and albumin may become an important reference index for clinical diagnosis and treatment of CHD, and the specific combination pattern among them may be used for clinical decision analysis. This evidence concerns the gene ALB and coronary artery disorder.